Barak Singer

Develops pharmaceutials for the treatment of ophthalmic disorders

Develops and sells orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction

Operates as an investment company

Trendlines is an active venture accelerator which invests in early-stage companies in the life sciences and homeland security sectors (medical devices, biotechnology, pharmaceuticals, microelectronics & software and material science & engineering). The firm aims to support their investee companies with an initial investment of approximately USD 60,000 plus a conditional grant of approximately USD 300,000 which is repaid from royalties on future sales of the products developed by the company. In addition to financing, Trendlines provides a variety of business development services to investee companies including management and marketing support, business insights, consultation, access to professional business consultants in Israel and the United States and a US marketing office. They sometimes make connections between inventors and entrepreneurs to offer inventors a hands-off option in moving their idea to incubator start-up.

Xenia Venture Capital (Xenia) focuses its investment efforts in life science companies located in the United States and Israel. The firm targets businesses operating in the fields of technology and medical devices. It typically provides equity financing ranging between USD 500,000 and USD 1 million for seed to early stage capital requirements. It also makes follow-on investments and co-invests alongside other venture capital firms.

Functions as a College/University

Develops bioactive bone graft material

Develops multi stall automatic robotic milking system

Develops repair system for meniscus tears of the knee